1. Home
  2. ACFN vs BEAT Comparison

ACFN vs BEAT Comparison

Compare ACFN & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACFN

Acorn Energy Inc.

HOLD

Current Price

$18.90

Market Cap

46.8M

ML Signal

HOLD

Logo Heartbeam Inc.

BEAT

Heartbeam Inc.

HOLD

Current Price

$0.86

Market Cap

44.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACFN
BEAT
Founded
1986
2015
Country
United States
United States
Employees
27
16
Industry
Military/Government/Technical
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
46.8M
44.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACFN
BEAT
Price
$18.90
$0.86
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.63
AVG Volume (30 Days)
10.1K
1.4M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$315.97
P/E Ratio
$6.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.42
$0.54
52 Week High
$33.00
$4.00

Technical Indicators

Market Signals
Indicator
ACFN
BEAT
Relative Strength Index (RSI) 53.86 34.95
Support Level $18.16 $0.80
Resistance Level $19.82 $1.29
Average True Range (ATR) 0.84 0.08
MACD 0.07 -0.00
Stochastic Oscillator 66.23 13.21

Price Performance

Historical Comparison
ACFN
BEAT

About ACFN Acorn Energy Inc.

Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. The company operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Share on Social Networks: